Emerging issues.  Guidance addresses H1N1 risks for individuals with HIV/AIDS.
D000998:Antiviral Agents / Q000627:therapeutic use; D019983:Guideline Adherence; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D008019:Life Style
D000998:Antiviral Agents